Industry News
Researchers Help In Search For New Ways To Image, Therapeutically Target Melanoma
Nov 04, 2011
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy... Read More
Gene Therapy Shows Promise As Hemophilia Treatment In Animal Studies
Nov 04, 2011
For the first time, researchers have combined gene therapy and stem cell transplantation to successfully reverse the severe, crippling bleeding disorder hemophilia A in large animals, opening the door to the development of new therapies for human patients... Read More
Details Of Alternative Splicing Circuitry That Promotes Cancer's Warburg Effect Revealed By Study
Nov 04, 2011
Cancer cells maintain their life-style of extremely rapid growth and proliferation thanks to an enzyme called PK-M2 (pyruvate kinase M2) that alters the cells' ability to metabolize glucose - a phenomenon known as the Warburg effect. Professor Adrian Krainer, Ph.D... Read More
Effectiveness And Safety Of New Treatment For Hemophilia Confirmed By Tulane-Led Study
Nov 04, 2011
An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events in people with a type of severe hemophilia can also be used to prevent such events from happening in the first place... Read More
Experimental Drug Shows Great Results On Prostate Cancer
Nov 04, 2011
An experimental drug known as MDV3100 made by Medivation Inc. has improved survival rates for men with metastatic castration-resistant prostate cancer. Those on MDV3100 by Medivation outlived those on a placebo by an average of 4.8 months, in a phase 3 trial. The manufacturer Medivation Inc... Read More
Discovery Whilst Studying Why Measles Spreads So Quickly Has Implications For Ovarian, Breast And Lung Cancers
Nov 04, 2011
Mayo Clinic researchers have discovered why measles, perhaps the most contagious viral disease in the world, spreads so quickly. The virus emerges in the trachea of its host, provoking a cough that fills the air with particles ready to infect the next host. The findings may also help in the fight against ovarian, breast and lung cancers... Read More
Potential Treatment For Sickle Cell Disease
Nov 04, 2011
A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease... Read More
Cetuximab Extends Lifespan Of Lung Cancer Patients With High EGFR Expression
Nov 03, 2011
A study published Online First in The Lancet Oncology reveals that patients who suffer from the most common form of lung cancer and whose tumors express high levels of epidermal growth factor receptor (EGFR) tend to benefit more from being treated with cetuximab and have a longer life-expectancy compared with those given chemotherapy alone... Read More
Prostate Cancer Survival Improves With Radiotherapy And Androgen Deprivation Therapy
Nov 03, 2011
An article published Online First in The Lancet reveals that men with locally advanced prostate cancer, which has not spread, who receive radiotherapy (RT) in combination with their androgen deprivation therapy (ADT) are more likely to have a greater overall chance of survival compared with those on ADT alone... Read More
Prostate Cancer Study Shows Radiation Plus Hormone Therapy Greatly Improves Survival For Men With High-Risk Disease
Nov 03, 2011
Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at the Princess Margaret Hospital (PMH) Cancer Program, University Health Network. The findings are published online today in The Lancet (doi: 10.1016/S0140-6736(11)61095-7)... Read More
Previous Page Next Page